# Cullinan Therapeutics, Inc.: Form 8-K/A, filed Jan 8, 2024

- Company: [Cullinan Therapeutics, Inc.](/companies/cgem.md) (CIK 1789972)
- Form: 8-K/A
- Filed: 2024-01-08
- Accepted by EDGAR: Jan 8, 2024, 21:15 ET
- Period: 2024-01-08
- Accession: 0000950170-24-002936
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1789972/000095017024002936/cgem-20240108.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1789972/000095017024002936/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1789972/000095017024002936/cgem-20240108.htm

Filed Jan 8, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-002936. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.